Authors:
Stick, S. M.; Sly, P. D.
Authors notes:
American Journal of Respiratory and Critical Care Medicine. 2011;183(12):1577-8
Keywords:
cystic fibrosis (CF), ion channel regulator, transmembrane conductance regulator, Denufosol
Abstract:
The recent announcement of the negative results of the TIGER-
2 phase 3 study of denufosol tetrasodium (Denufosol; Inspire
Pharmaceuticals, Chapel Hill, NC) has had a considerable impact
on the cystic fibrosis (CF) community, researchers, and industry.